Apollomics Inc.
APLM · Nasdaq · United States
Share price · APLM
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Adjusted for stock splits · Data via Databento
Unusual price moves
Days when APLM's shares moved far more than they usually do, with what was announced that day or the session before. An announcement on the same day does not show that it caused the move. How the days are picked
- 14 Aug 2026+34.7%
- 17 Jul 2026-20.4%
Nothing announced by APLM that day or the session before.
- 16 Jul 2026+21.3%
Nothing announced by APLM that day or the session before.
- 15 Jul 2026+22.2%
- 13 Jul 2026-25.0%
- 22 Jun 2026+30.5%
Nothing announced by APLM that day or the session before.
- 18 Jun 2026+25.3%
Nothing announced by APLM that day or the session before.
- 15 May 2026+10.3%
Nothing announced by APLM that day or the session before.
- 1 May 2026+24.8%
Nothing announced by APLM that day or the session before.
- 2 Feb 2026+19.0%
Nothing announced by APLM that day or the session before.
Share of unusual movement by asset
For each asset, the share of APLM's own-move activity since 2 Jul 2024 that fell on the session of one of the asset's own announcements or the session after it. Large moves count for much more than small ones. A session shared by several assets is split between them. A share is shown once an asset has at least 8 event days; below that, its events are listed instead.
| Asset | Event days | Share of unusual movement |
|---|---|---|
Vebreltinibevents and moves
| 2 | shown from 8 days |
| Assets with fewer than 8 event days, together | — | 1% |
| Other company news (earnings, financing, releases naming no asset) | — | 21% |
| Sessions with no dated event | — | 79% |
Assets
(1 total)
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | METSmall molecule | Non-Small Cell Lung CancerGlioma Non-Small Cell Lung Cancer with MET Exon 14 Skipping |
Upcoming events
(2 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Regulatory and conference events
(1)
Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.
Recent
Financial reports
Annual history (5 years)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-FY | $8.5M | $5.5M | $3.3M | $2.7M | report ↗ |
Insider transactions
Open-market activity, trailing 12 months: 5 purchases ($8.3M), 0 sales ($0). Awards, option exercises and tax-withholding rows are listed below but excluded from these totals.
| Source | ||||||
|---|---|---|---|---|---|---|
| 2026-11-17 | Huang Ya-Chi · director | Option exercise | 500 | — | — | Form 4 |
| 2026-11-17 | Huang Ya-Chi · director | Option exercise (derivative) | 500 | — | — | Form 4 |
| 2026-09-15 | Yen Hung Hsien · director | Option exercise | 500 | — | — | Form 4 |
| 2026-09-15 | LIN PETER KUAN-HOW · Chief Financial Officer | Option exercise | 10,000 | — | — | Form 4 |
| 2026-09-15 | Chen Yi-Kuei · director, Chief Operating Officer | Option exercise | 5,000 | — | — | Form 4 |
| 2026-09-15 | LIN PETER KUAN-HOW · Chief Financial Officer | Tax withholding | 3,416 | $24.02 | $82K | Form 4 |
| 2026-09-15 | Yen Hung Hsien · director | Option exercise (derivative) | 500 | — | — | Form 4 |
| 2026-09-15 | Chen Yi-Kuei · director, Chief Operating Officer | Option exercise (derivative) | 5,000 | — | — | Form 4 |
Institutional holders
From SEC Form 13F filings for the quarter ended 2026-03-31 (filed up to 45 days later). 4 reporting institutions held 0.0M shares ($9K, 0.0% of shares outstanding).
| # | Institution | Shares | Value |
|---|---|---|---|
| 1 | CITIGROUP INC | 438 | $7K |
| 2 | UBS Group AG | 142 | $2K |
| 3 | SBI Securities Co., Ltd. | 9 | $143 |
| 4 | BlackRock, Inc. | 1 | $16 |